COVID-19 in naval military health establishment, Bogotá D.C., epidemiological weeks 13 of 2020 to 49 of 2021
DOI:
https://doi.org/10.33610/28059611.136Keywords:
coronavirus, disease outbreaks, Epidemiology, military personnelAbstract
Introduction: The first case of COVID-19 among naval health personnel in Colombia was recorded in epidemiological week 13 of 2020. This case originated in a highly complex military health institution.
Methods: A descriptive study of the outbreak was carried out, in which risk management activities were implemented. The demographic characteristics of the affected persons were analyzed, the attack rate was calculated and the incidence was evaluated in naval health facilities at national and local level. In addition, an epidemic curve was developed. The results are presented in tables and graphs.
Results: The incidence of the outbreak in the military health establishment in Bogotá D.C. was 46 in 2020 and 49 per 1,000 inhabitants in 2021. In addition, greater spread of the virus was observed during the peaks of circulation and active transmission of SARS-CoV-2 in the national territory and in Bogotá, D.C.
Conclusions: The attack rate was 1.6%, lower than that reported nationally. The preparedness, containment, and mitigation phases implemented in risk management during the COVID-19 pandemic in naval health personnel led to improved surveillance and response to the outbreak.
References
OPS/OMS. Actualización Epidemiológica Nuevo coronavirus (2019-nCoV) 27 de enero de 2020. Pan American Health Organization/World Health Organization. 2020.
INS. Anexo. Instructivo para la vigilancia en salud pública intensificada de infección respiratoria aguda grave asociada al nuevo coronavirus 2019 (COVID-19). 2020;1–6.
MSPS. Resolucion Numero 8430 de 1993. 1993 p. 1–19.
Díaz-Castrillón FJ, Toro-Montoya AI. SARS-CoV-2/COVID-19: el virus, la enfermedad y la pandemia. Med. Lab. [Internet]. 5 de mayo de 2020 [citado 9 de mayo de 2022];24(3):183-05. Disponible en: https://medicinaylaboratorio.com/index. php/myl/article/view/268
Serra Valdés M. Las enfermedades crónicas no transmisibles y la pandemia por COVID-19. Revista Finlay [Internet]. 2020;10(2):[aprox. 10 p.]. Acceso: 26/11/2020. Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/ view/846
Espin Falcón JC, Cardona Almeida A, Miret Navarro LM, González Quintana M. La COVID-19 y su impacto en la salud del adulto mayor. Arch Hosp Univ “Gen Calixto García” [Internet]. 2020;8(3):391-403. Acceso: 18/07/2021. Disponible en: http://www.revcalixto.sld.cu/index.php/ahcg/article/view/568
Halm A, Seyler T, Mohamed S, Mbaé SBA, Randrianarivo-Solofoniaina AE, Ratsitorahina M, et al. Four years into the indian ocean field epidemiology training programme. Pan Afr Med J. 2017;26:1–11.
Urquía ML. Teorías dominantes y alternativas en epidemiología. 2019. Internet]. 2020;8(3):391-403. Acceso: 18/07/2021. Disponible en http://capacitasalud.com/wp-content/uploads/2019/02/Teorias-dominantes-y-alternativas-de-la-epidemiologia.pdf
Werneck L. 2019. La pandemia de COVID-19: desafíos en la evaluación del impacto de problemas complejos y multidimensionales en la salud de poblaciones
Langmuir AD. The Epidemic Intelligence Service of the Center for Disease Control. Public Health Rep. 1980;95(5):470–7.
LANGMUIR AD, ANDREWS JM. Biological warfare defense. 2. The Epidemic Intelligence Service of the Communicable Disease Center. Am J Public Health. 1952;42(3):235–8.
Ostroff SM. The Epidemic Intelligence Service in the United States. Euro Surveill. 2001;6(3):34–6.
Langmuir AD. The surveillance of communicable diseases of national importance. N Engl J Med. 1963;268(4):182.
Patino LH, Mendez C, Rodriguez O, Romero Y, Velandia D, Alvarado M, et al. Spatial distribution, Leishmania species and clinical traits of Cutaneous Leishmaniasis cases in the Colombian army. PLoS Negl Trop Dis. 2017;11(8):1–15.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Reporte Epidemiológico Nacional
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
